• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Global Medical REIT Inc.

    8/12/24 4:30:52 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate
    Get the next $GMRE alert in real time by email
    S-8 1 tm2421279d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on August 12, 2024

     

    Registration No. 333-

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

     

     

    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

     

     

     

    GLOBAL MEDICAL REIT INC.
    (Exact name of registrant as specified in its charter)
     
    Maryland   46-4757266
    (State or Other Jurisdiction
    of Incorporation or Organization)
      (I.R.S. Employer
    Identification No.)
         
    7373 Wisconsin Avenue, Suite 800
    Bethesda, Maryland
      20814
    (Address of Principal Executive Offices)   (Zip Code)

       
    Global Medical REIT Inc. 2016 Equity Incentive Plan
    (Full title of the plan)

       

    Jeffrey M. Busch
    7373 Wisconsin Avenue, Suite 800
    Bethesda, Maryland 20814

    (Name and address of agent for service)

       
    (202) 524-6851
    (Telephone number, including area code, of agent for service)

     

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

     

    Large accelerated filer x   Accelerated filer ¨
    Non-accelerated filer ¨   Smaller reporting company ¨
          Emerging growth company ¨ 

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”). ¨

     

     

     

     

     

    INTRODUCTORY STATEMENT

     

    Global Medical REIT Inc., a Maryland corporation (the “Registrant”), is filing this Registration Statement on Form S-8 (the “Registration Statement”) for the purpose of registering the offer and sale of an additional 1,650,000 shares of its common stock, par value $0.001 per share (“Stock”), issuable pursuant to the terms of the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”).

     

    Pursuant to General Instruction E to Form S-8, the Registrant hereby incorporates by reference into this Registration Statement the contents of the prior registration statements on Form S-8 filed by the Registrant with the Securities and Exchange Commission (the “Commission”) on (i) June 30, 2016 (File No. 333-212343) relating to the Plan, (ii) June 21, 2019 (File No. 333-232279) relating to an amendment to the Plan, and (iii) March 2, 2022 (File No. 333-263219) relating to an amendment to the Plan (collectively, the “Prior Registration Statements”), including periodic reports that the Registrant filed after the Prior Registration Statements to maintain current information about the Registrant except to the extent otherwise updated or modified by this Registration Statement. The additional shares of Stock that are the subject of this Registration Statement were authorized pursuant to an amendment to the Plan that was approved by the Registrant’s stockholders on May 15, 2024, which Stock consists of shares reserved and available for delivery with respect to awards under the Plan and additional shares that may again become available for delivery with respect to awards under the Plan pursuant to the share counting, share recycling and other terms and conditions of the Plan.

     

    PART I
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

     

    In accordance with the instructional note to Part I of Form S-8, as promulgated by the SEC, the information specified by Part I of Form S-8 has been omitted from this Registration Statement. The documents containing the information specified in Part I will be delivered to the participants in the Plan covered by this Registration Statement as required by Rule 428(b)(1) under the Securities Act.

     

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 8.Exhibits.

     

    Exhibit
    Number
      Description
    4.1  Articles of Restatement of Global Medical REIT Inc. (incorporated herein by reference to Exhibit 3.1 to the Company’s Report on Form 10-Q as filed with the SEC on August 8, 2018).
        
    4.2  Fourth Amended and Restated Bylaws of Global Medical REIT Inc., adopted as of December 7, 2022 (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K as filed with the SEC on December 7, 2022).
        
    4.3  Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended through May 15, 2024) (incorporated  herein by reference to Appendix A of the Company's Definitive Proxy Statement on Schedule 14A as filed with the SEC on April 1, 2024).
        
    5.1*  Opinion of Venable LLP as to the legality of the securities being registered.
        
    23.1*  Consent of Deloitte & Touche, LLP.
        
    23.2*  Consent of Venable LLP (contained in Exhibit 5.1 hereto).
        
    24.1*  Power of Attorney (included as part of the signature pages to this Registration Statement).
        
    107.1*  Calculation of Filing Fee Tables

     

     

    * Filed herewith.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bethesda, State of Maryland, on August 12, 2024.

     

      GLOBAL MEDICAL REIT INC.
       
      By: /s/ Jeffrey M. Busch
        Name: Jeffrey M. Busch
        Title: Chief Executive Officer (Principal Executive Officer)

     

    POWER OF ATTORNEY

     

    KNOWN ALL PERSONS BY THESE PRESENTS, pursuant to the requirements of the Securities Act, that each person whose signature appears below authorizes and appoints Jeffrey M. Busch as such person’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead in any and all capacities to sign any and all amendments (including post-effective amendments) to this Registration Statement and any additional registration statement pursuant to Rule 462(b) under the Securities Act, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully and to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or such person’s or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

     

    Signature   Title
         
    /s/ Jeffrey M. Busch   Chief Executive Officer and Director
    Jeffrey M. Busch   (Principal Executive Officer)
         
    /s/ Robert J. Kiernan   Chief Financial Officer
    Robert J. Kiernan   (Principal Financial and Accounting Officer)
         
    /s/ Henry Cole   Director
    Henry Cole    
         
    /s/ Paula Crowley   Director
    Paula Crowley    
         
    /s/ Matthew Cypher   Director
    Matthew Cypher    
         
    /s/ Zhang Huiqi   Director
    Zhang Huiqi    
         
    /s/ Ronald Marston   Director
    Ronald Marston    
         
    /s/ Lori Wittman   Director
    Lori Wittman    
         

     

    3

     

    Get the next $GMRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GMRE

    DatePrice TargetRatingAnalyst
    10/13/2025$40.00Mkt Perform → Mkt Outperform
    Citizens JMP
    4/3/2025$9.00Neutral
    B. Riley Securities
    10/18/2024$11.75Buy
    Berenberg
    9/19/2024$12.00Buy
    Alliance Global Partners
    10/10/2022$9.00Outperform → Neutral
    Robert W. Baird
    10/6/2022$13.00 → $9.00Outperform → Market Perform
    BMO Capital Markets
    7/7/2022Mkt Perform
    JMP Securities
    1/13/2022Overweight → Sector Weight
    Keybanc
    More analyst ratings

    $GMRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Global Medical REIT upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Global Medical REIT from Mkt Perform to Mkt Outperform and set a new price target of $40.00

    10/13/25 8:40:10 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    B. Riley Securities resumed coverage on Global Medical REIT with a new price target

    B. Riley Securities resumed coverage of Global Medical REIT with a rating of Neutral and set a new price target of $9.00

    4/3/25 8:18:01 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Berenberg initiated coverage on Global Medical REIT with a new price target

    Berenberg initiated coverage of Global Medical REIT with a rating of Buy and set a new price target of $11.75

    10/18/24 7:31:30 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Decker Mark Okey Jr bought $325,100 worth of shares (10,000 units at $32.51), increasing direct ownership by 22% to 54,774 units (SEC Form 4)

    4 - Global Medical REIT Inc. (0001533615) (Issuer)

    12/8/25 4:15:28 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    CFO and Treasurer Kiernan Robert J bought $95,730 worth of shares (3,000 units at $31.91) (SEC Form 4)

    4 - Global Medical REIT Inc. (0001533615) (Issuer)

    11/17/25 8:09:35 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    CEO and President Decker Mark Okey Jr bought $325,813 worth of shares (10,000 units at $32.58), increasing direct ownership by 29% to 44,774 units (SEC Form 4)

    4 - Global Medical REIT Inc. (0001533615) (Issuer)

    11/17/25 8:08:59 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley. Please note, at the time it releases its fourth quarter and year-end 2025 financial results, the Company's previously

    2/11/26 4:17:00 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to "Chiron Real Estate Inc." Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the "NYSE") under the new name, "Chiron Real Estate Inc.," and ticker symbol "XRN." "After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission," Mark Decker, Jr., Chief Executive Officer, said. "Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered a

    2/3/26 8:00:00 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Global Medical REIT Reports Tax Treatment of 2025 Dividends

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to reflect the Company's one-for-five reverse stock split that was effective on September 19, 2025. Stockholders should review their Forms 1099 as well as other 2025 tax statements that they will receive from their brokerage firms or o

    1/27/26 8:00:00 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Decker Mark Okey Jr bought $325,100 worth of shares (10,000 units at $32.51), increasing direct ownership by 22% to 54,774 units (SEC Form 4)

    4 - Global Medical REIT Inc. (0001533615) (Issuer)

    12/8/25 4:15:28 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    CFO and Treasurer Kiernan Robert J bought $95,730 worth of shares (3,000 units at $31.91) (SEC Form 4)

    4 - Global Medical REIT Inc. (0001533615) (Issuer)

    11/17/25 8:09:35 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    CEO and President Decker Mark Okey Jr bought $325,813 worth of shares (10,000 units at $32.58), increasing direct ownership by 29% to 44,774 units (SEC Form 4)

    4 - Global Medical REIT Inc. (0001533615) (Issuer)

    11/17/25 8:08:59 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    SEC Filings

    View All

    Global Medical REIT Inc. filed SEC Form 8-K: Leadership Update

    8-K - Global Medical REIT Inc. (0001533615) (Filer)

    1/26/26 4:15:50 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Global Medical REIT Inc. filed SEC Form 8-K: Leadership Update

    8-K - Global Medical REIT Inc. (0001533615) (Filer)

    12/4/25 4:22:32 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    SEC Form CERT filed by Global Medical REIT Inc.

    CERT - Global Medical REIT Inc. (0001533615) (Filer)

    11/18/25 4:56:18 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    Leadership Updates

    Live Leadership Updates

    View All

    Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that Ronald Marston has notified the Board of Directors (the "Board") that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at different points throughout his tenure has served as the chair of the Board's Nominating and Corporate Governance Committee as well as a member of the Board's Audit and Compensation Committees. Mr. Marston's retirement will be effective

    12/4/25 4:10:00 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Ortelius Director Nominees Release Joint Letter to Brookdale Stockholders

    Ortelius Nominees Believe Brookdale Offers a Tremendous Value Creation Opportunity Under a Renewed Board and New Strategic Roadmap Six Highly Qualified and Independent Nominees Will Act with Urgency, Integrity, and Transparency to Increase Value for Stockholders Brookdale Stockholders are Urged to Vote the WHITE Proxy Card FOR all Six Ortelius Nominees Ortelius Advisors, L.P. ("Ortelius") today announced that the six highly qualified individuals nominated by Ortelius for election to the Board of Directors (the "Board") of Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") at the upcoming 2025 Annual Meeting of Stockholders released a joint letter to Brookdale stock

    7/3/25 8:00:00 AM ET
    $BKD
    $GMRE
    $NTST
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Global Medical REIT Appoints Mark Decker, Jr. as CEO

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), today announced that Mark Decker, Jr. has been appointed as the Company's Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of Directors, succeeds Jeffrey Busch, who will continue to serve on the Board as non-executive Chairman. Lori Wittman, Lead Independent Director of the Company stated, "We are extremely pleased to announce Mark Decker, Jr. as our new Chief Executive Officer. As part of the Board's ongoing commitment and efforts to maximize shareholder value, we identified the need for a fresh, strategic perspective to guide our portfolio management and growth initiatives. M

    6/23/25 7:00:00 AM ET
    $CSR
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    Financials

    Live finance-specific insights

    View All

    Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley. Please note, at the time it releases its fourth quarter and year-end 2025 financial results, the Company's previously

    2/11/26 4:17:00 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE") today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to "Chiron Real Estate Inc." Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the "NYSE") under the new name, "Chiron Real Estate Inc.," and ticker symbol "XRN." "After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission," Mark Decker, Jr., Chief Executive Officer, said. "Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered a

    2/3/26 8:00:00 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    Global Medical REIT Reports Tax Treatment of 2025 Dividends

    Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to reflect the Company's one-for-five reverse stock split that was effective on September 19, 2025. Stockholders should review their Forms 1099 as well as other 2025 tax statements that they will receive from their brokerage firms or o

    1/27/26 8:00:00 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    $GMRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Global Medical REIT Inc. (Amendment)

    SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

    1/25/24 4:59:30 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Global Medical REIT Inc. (Amendment)

    SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

    2/9/23 11:19:25 AM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Global Medical REIT Inc. (Amendment)

    SC 13G/A - Global Medical REIT Inc. (0001533615) (Subject)

    1/31/23 1:58:04 PM ET
    $GMRE
    Real Estate Investment Trusts
    Real Estate